Breast Cancer

  • Perjeta 2019 report

    Perjeta 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Piqray 2019 report

    Piqray 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Talzenna 2019 report

    Talzenna 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Tecentriq 2019 report

    Tecentriq 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 22 Pages The 5 Key Questions Addressed by this Report:...

  • Verzenio 2019 report

    Verzenio 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 25 Pages The 5 Key Questions Addressed by this Report:...

  • Abraxane 2018 report

    Abraxane 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 29 Pages The 5 Key Questions Addressed by this Report:...

  • Afinitor 2018 report

    Afinitor 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 31 Pages The 5 Key Questions Addressed by this Report:...

  • Avastin 2018 report

    Avastin 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 25 Pages The 5 Key Questions Addressed by this Report:...

  • Fareston 2018 report

    Fareston 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Faslodex 2018 report

    Faslodex 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 29 Pages The 5 Key Questions Addressed by this Report:...

  • Halaven 2018 report

    Halaven 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Herceptin 2018 report

    Herceptin 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 24 Pages The 5 Key Questions Addressed by this Report:...